-
Product Insights
Vast Solar Jemalong Solar PV Park
Vast Solar Jemalong Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned by Genex Power Ltd and was developed by Genex Power Ltd; Vast Solar Pty Ltd. The project came online in 2021. Empower your strategies with our Vast Solar Jemalong Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
Vast Solar Australia Hybrid Solar PV Park
Vast Solar Australia Hybrid Solar PV Park is a solar PV project located in Queensland, Australia. The project is owned and being developed by Vast Solar Pty Ltd. The project is at the permitting stage. Empower your strategies with our Vast Solar Australia Hybrid Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
GlobalData's latest Innovation Radar report "New Prescription: Generative AI Meets Healthcare (Vol. 2)," expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and healthcare sectors. This volume dives into recent real-world applications where generative AI is advancing across drug discovery, diagnostics, clinical documentation, and patient support. From harnessing vast datasets to expediting R&D breakthroughs and refining patient care through lifelike speech synthesis, this report unveils the ongoing evolution of generative AI in...
-
Product Insights
NewNet Present Value Model: Inhibrx Inc’s INBRX-101
Empower your strategies with our Net Present Value Model: Inhibrx Inc's INBRX-101 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed based...
-
Sector Analysis
NewSmart Cities Market Trends and Analysis by Application, IT Component, Vertical, Region, and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Smart Cities’ report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Smart...
-
Product Insights
Bronchiectasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bronchiectasis - Drugs In Development, 2023’, provides an overview of the Bronchiectasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
EMEA Alcoholic Beverages Sport Sponsorship Landscape – Biggest Brands and Spenders, Venue Rights, Deals, Trends and Case Studies
EMEA Alcoholic Beverages Sport Sponsorship Report Overview The EMEA alcoholic beverages sector has recorded an estimated annual spend of $ 403.66 million in sports sponsorship for 2023. There are 338 different brands currently engaged in sports sponsorship agreements across EMEA. There has been an increase in deal value owing to the mutually beneficial partnerships between alcoholic beverage brands and sports rights holders. These sports partnerships offer immense opportunities for the alcoholic beverages brands to raise the profile of the brand...
-
Product Insights
United Kingdom (UK) SME Insurance Market Size, Trends, Competitor Dynamics and Opportunities
United Kingdom (UK) SME Insurance Market Report Overview The UK SME insurance market generated gross written premiums (GWP) worth GBP15.52 billion in 2023. The primary factor contributing to GWP growth in 2023 was a large year-round hardening of premiums. The rise in claims expenses, which were often passed on to customers, also contributed to the overall increase in GWP. Various insurance categories witnessed substantial increases in the cost of coverage, primarily due to inflationary pressures and challenges in the global...
-
Analyst Opinions
Australia Wealth Management – Market Sizing and Opportunities to 2027
Australia Wealth Management Report Overview Affluent individuals (including HNW individuals and mass affluents) collectively held the vast majority of onshore liquid assets, highlighting the country’s high level of wealth imbalance. The equities market recorded significant volatility resulting in a decline. Additionally, inflationary pressures and supply chain disruptions across 2022 and 2023 translated into more depressed financial markets, thus impacting investor sentiment. The Australia Wealth Management market research report will help to keep up to date with the Australian wealth management...
-
Product Insights
Cystic Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cystic Fibrosis - Drugs In Development, 2023’, provides an overview of the Cystic Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cystic Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...